• Skip to primary navigation
  • Skip to main content

Destum Partners

Bridging the Gap Between Science and Business

  • HOME
  • SERVICES
    • ADVISORY PRACTICES
    • CONSULTING PRACTICES
  • SUCCESS
    • ADVISORY
    • CONSULTING
  • ABOUT
  • NEWS & EVENTS
  • CONTACT

April 14, 2016 By

Innopharmax and Avir announce a License Agreement

[Times – Taipei] China (4172) signed licensing, supply and distribution agreements with Avir Pharma, Canada. For this reason, the contract sales region includes the sole agent of Canada, and Saudi Arabia, the United Arab Emirates, Qatar, Oman, Kuwait, Lebanon non-exclusive agent. The main terms of this contract, due to the development of China, production and supply responsibility; Avir Pharma marketing, distribution of drugs. The contract period is 7 years after the product is marketed. If the contract expires 2 years before the expiration of the contract, the contract will be renewed for 5 years, including the future supply conditions and authorization. (Edited by: Li Huilan)

Read More >

Filed Under: NEWS

Bill Rickrode

WORK WITH US

Destum Partners serves an exclusive clientele with a shared passion for business and science. Our Clients range from multinational fortune 500 companies to midsized and early stage privately held companies. We truly have a global reach, with Clients in our portfolio based in Asia, Europe and the Americas.

    Copyright © 2026 · Destum Partners · All Rights Reserved.